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Methods: A cross-sectional study was conducted on a
selected sample of adolescents and adults in the Muhayil
Aseer region of KSA. A comprehensive questionnaire-
based interview was performed for all participants,
blood samples were taken, and sera were tested for
HBsAg.
Results: The study included 133 adolescents and 938
adults. A seroprevalence of 1.5% and 6.1% were recor-
ded among adolescents and adults, respectively. The
study showed that persons without the hepatitis B
vaccination carried a significantly higher risk for devel-
oping sero-positivity for HBsAg.
Conclusion: The present study further endorsed the
effectiveness of vaccination in preventing hepatitis B virus
(HBV) infection. Strict preventive measures against HBV
infection need to be fostered in the study area.
Keywords: Adolescents; HBsAg seroprevalence; HBV;
Muhayil Aseer; Vaccination
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Earlier studies and reports dating back to 1980 on the
seroprevalence of hepatitis B virus (HBV) infection in KSAhis is an open access article under the CC BY-NC-ND license
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S.M. Al Humayed 141that were compiled and further analysed by Al-Faleh in
20031 have documented a high endemicity of HBV
infection: 5e10% of the population were infected. The
highest rate of infection was in the southern region of
KSA. By 1989, a year prior to the addition of the HBV
vaccine to the Extended Program of Immunization (EPI),
the prevalence of HBV infection among children was 7%.
Consequently a mass vaccination program was launched
in that year.2 Eventually, a steady significant decline of
HBV infection among children was observed.1,3 In 2008, a
sero-survey was conducted in regions of different HBV
endemicity and Al-Faleh et al. documented a zero preva-
lence of HBsAg among students (16e18 years of age) in
Almadinah Almunawwarah and Al-Qaseem both of which
are located in the Aseer region, the region with the highest
endemicity, thus documenting the efficacy of the HBV
vaccine and its long-term protection.4 According to the
Ministry of Health, new cases of HBV infection (4259)
reported in 2013 amounted to 70% of all reported cases
(6106) of viral hepatitis.5
Previously in KSA, the HBV vaccine was given in three
doses (0, 1 and 5 months).6 However, as of January 2013, the
schedule has been revised and re-adjusted: commencing at
birth and continuing at 2-month intervals for a total of four
doses. Strict measures are undertaken by the authorities to
ensure that all children complete their EPI. Since the intro-
duction of the HBV vaccination in 1990, it is expected that all
children and adults of 25 years of age or younger have been
vaccinated against HBV.
The objective of this work was to investigate the sero-
prevalence of HBsAg among adolescents and adults utilizing
a sensitive enzyme immunoassay capable of detecting less
than 0.1 WHO IU/ml HBsAg in Muhayil Aseer, located in
southwest KSA. In addition, relevant risk factors were
studied in the selected area.
Materials and Methods
Settings
The study was a cross-sectional study on a representative
sample of adolescents and adults in theMuhayil Aseer region
of KSA.
The study area
The Aseer region is located in the southwest of KSA and
covers an area of more than 80,000 km2. It borders Jizan and
is located to its northeast. The region is divided into 11
Governorates. The Muhayil Governorate is the location of
the current study (Figure 1) and has a total population of
214,758 (Saudi Central Department of Statistics and
Information, 2013). Health care is provided through a
network of 36 primary health care centres and a general
hospital, the Muhayil General Hospital.
Sampling procedures
During late 2014, patients and their relatives who were
aged 10 years or older and attended the outpatients’ clinics ofMuhayil General Hospital for any reason (attending clinics,
doing any laboratory investigation, blood donation and pre-
marital screening) were included in the sample.
Questionnaire interview
A comprehensive questionnaire interview was offered to
all participants. The questionnaire included socio-
demographic data and history of relevant exposures. His-
tory of blood transfusion was also enquired about. Similarly,
the following data were collected: history of any surgical
operations, tooth extraction, wet cupping and hepatitis B
vaccination.
Ethical approval
The study was reviewed and approved by the ethical
committee of King Khalid University. Informed consent was
obtained from each individual.
Blood sampling
Approximately 5- to 10-ml venous blood samples in plain
tubes were taken from each participant and were allowed to
clot at room temperature (range 18 Ce20 C). Samples were
then centrifuged at 10,000 rpm for 10 min, and the separated
sera were aliquoted into two portions and stored at 20 C
until transported in ice boxes to the Virus Lab of the Abha
College of Medicine, where they were grouped by collection
area and stored in classified boxes in similar conditions as
described above.
Serologic tests for HBsAg
HBsAg was tested by a fourth generation enzyme
immunoassay (ELISA) obtained from DIA.PRO Diagnostic
Bioprobes Sr1 via G. Carducci, Milano, Italy. Briefly, the
sold phase was pre-coated with mouse monoclonal anti-
bodies specific to the sub determinants a, d and y. Test sera
were reacted with these antibodies, incubated and washed.
The captured HBsAg was further reacted with conjugated
mouse monoclonal antibodies against those sub de-
terminants. Test plates were subsequently washed and reac-
ted with a substrate. The resulting colour was read by a
double beam multi-scan ELISA reader at 450 nm. The
manufacturer’s protocols were strictly followed in testing
and interpreting the results.
Statistical analysis
Data were coded, validated and analysed using the Sta-
tistical Package for the Social Sciences (SPSS), version 13.0
(SPSS Inc., Chicago, IL, USA). The frequency, percentage,
arithmetic mean, and mode are used to present the data. The
chi-square test and Fishers’ exact test were used as tests of
significance at a 5% level of significance. Binary logistic
multivariate analysis, adjusted odds ratio and antecedent
95% CIs were used to identify potential risk factors for
HBsAg seropositivity.
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Figure 1: Map showing the Aseer region and Muhayil area.
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Description of the study sample
The present study included 1071 persons in the Muhayil
Aseer region of KSA. Participant’s ages ranged from 10 to 72
years with an average age of 35.4  17.8 years and a median
of 30 years. The presents study included 133 (12.4%) ado-
lescents (aged 11e19 years) and 938 adults (20 years and
older). Regarding sex distribution, 50.4% (67) of adolescents
and 51.1% (479) of adults were males. The gender difference
was not statistically significant (c2 ¼ 0.222, P ¼ 0.882).
Regarding the marital status among adults, 75.2% were
married, 20.1% were widowed or divorced, and the rest were
single. The majority of adolescents (96.3%) were single. The
majority of adult females (95.1%) were housewives. The
highest proportion of adult males (45.3%) were either
farmers or shepherds. As for the level of education of adults,
24.5% were illiterate. Very few (2.3%) were university
educated.1.5
0
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Figure 2: Seroprevalence of Hepatitis B (HBsAg) Viral Infections
among the study sample of adolescents and adults in the Muhayil
Aseer region of KSA.History of relevant exposures
History of blood transfusion among adolescents (1.5%,
2) was not significantly different (c2 ¼ 0.153, P ¼ 0.283)
from that of adults (3.1%, 3.0). Similarly, history of sur-
gical operations and history of wet cupping were not
significantly different among adolescents and adults.
However, history of hepatitis B vaccination was signifi-
cantly higher among adolescents (64.7%, 86) compared to
adults (24.9%, 234).Sero-prevalence of hepatitis B (HBsAg)
Two adolescents tested positive for the hepatitis B surface
antigen, giving a sero-prevalence of 1.5%. Among the adults,
57 tested positive for the hepatitis B surface antigen, giving a
sero-prevalence of 6.1% (Figure 2).The age difference was
statistically significant (c2 ¼ 4.681, P ¼ 0.015) (see Table 1).
Determinants of HBsAg sero-positivity
Multivariate binary logistic regression analysis was used to
identify potential risk factors associated with HBsAg sero-
positivity (Table 2). After adjusting for other potential risk
Table 1: Distribution of the study sample of adolescents (aged
10e19 years) and adults (aged 20 years and older) in the
Muhayil Aseer region, by relevant exposures and
seropositivity.
Variable Adolescents
(N ¼ 133)
Adults
(N ¼ 938)
P value
Number % Number %
History of blood
transfusion
2 1.5 30 3.2 0.283
History of surgical
operations
2 1.5 43 4.6 0.109
History of tooth
extraction
4 3.0 88 9.4 0.012
History of wet cupping 0 0.0 22 2.3 0.098
History of hepatitis
B vaccination
86 64.7 234 24.9 0.001
HBsAg seropositive 2 1.5 57 6.1 0.015
Table 2: Multivariate analysis, adjusted Odds ratio (aOR) and
antecedent 95% confidence intervals (CI) of potential risk
factors determining sero-positive HBsAg in the Muhayil Aseer
region of KSA.
Variable aOR 95% CI
Lower Upper
Gender: Males vs. Females 1.024 0.591 1.776
History of blood transfusiona:
Yes vs. No
2.704 0.909 8.048
History of any surgical operation:
Yes vs. No
1.652 0.605 4.514
History of tooth extraction:
Yes vs. No
1.811 0.847 3.871
History of wet cupping: Yes vs. No 1.125 0.236 5.378
History of yellow eye in adulthood:
Yes vs. No
1.076 0.279 4.149
History of hepatitis B vaccinationa:
No vs. Yes
2.792 1.182 6.623
a Significant (P < 0.05).
S.M. Al Humayed 143factors, the study showed that persons without the hepatitis B
vaccination had more than two times the risk to become sero-
positive for HBsAg (aOR ¼ 2.792, 95% CI: 1.182e6.623).
Conversely, gender, andhistory of other exposureswere found
to be of no significance in developing sero-positive HBsAg.Discussion
Hepatitis B virus infection (HBV) is a major cause of
chronic liver disease worldwide.7 Data from the World
Health Organization (WHO) estimates the burden of HBV
infection to be approximately 2 billion cases with more
than 240 million known to be chronically infected.8 In
addition, more than half a million patients worldwide die
annually as a result of HBV-related liver diseases, such as
decompensated liver cirrhosis, end-stage liver disease or he-
patocellular carcinomas.9
HBV infection is endemic in KSA. A plethora of studies
have been published since 1984 addressing various aspects ofthe disease: its prevalence among the general population and
the different age groups in the Kingdom,1,4,10e13 blood
donors,14e17 health care workers,18 pregnant women,19e21
disease patterns,22,23 virus genotypes and its relation to
hepatocellular carcinoma.24,25
Although the general trend of HBV infection in KSA is
declining,3 this infection remains a significant challenge. The
Saudi Ministry of Health Statistics Year Book of 2013
reported a total of 6106 new cases of viral hepatitis of
which 70% (4259) were due to HBV infection.5 The
present study showed that there were only two adolescents
(1.5%) infected with HBV, in contradistinction to 57
adults (6.1%). It is expected that adolescents would have
received the HBV vaccination as part of the Saudi EPI.
However, only 64.7% of adolescents in the present study
reported that they were vaccinated. The two adolescents
who were found to be sero-positive were among the one
third who gave no history of vaccination and likely acquired
their infection from either tooth extraction or surgical
operations.
The low seroprevalence of HBV infection among adoles-
cents in this study confirms the previous findings of others3,4
and highlights the effectiveness of vaccination in preventing
HBV infection. Furthermore, the effectiveness of
vaccination was also reflected in the relative high rate of
HBV infection among adults (6.1%), most of who were not
vaccinated and were exposed to the risk factors of
acquiring the infection investigated in this study. This rate
of infection among adults is higher than the range of
1.5%e2.6% reported by Memish et al., in 2010.26 The
assay employed in this study is capable of detecting very
low quantities of HBsAg (<0.1 WHO IU/ml HbsAg), thus
the sensitivity of this assay may be higher than that of
earlier assays employed in previous studies and might
explain the higher rate found in this study.
Although wet cupping, a common practice in KSA, was
not implicated in the transmission of HBV infection in this
study, it was found by Alothman and Al Ghamdi to be the
only plausible risk factor for transmission of HIV to a Saudi
citizen.27 The equipment used for wet cupping is available as
disposable off-the-shelf items in local pharmacies. Therefore,
health education in such remote areas must take into
consideration the local habits and practices that may play a
role in HBV transmission.
Prevention of HBV infection can be achieved through a
variety of actions. Advocacy and continuous efforts to raise
awareness of HBV infections among the general population
will help to reduce transmission in the general community
and in remote areas such as Muhayil, the focus region of the
present study. Strengthening efforts to keep coverage of the
HBV vaccine in the EPI programs of the affected areas is also
important. Implementation of strict blood safety strategies
that include keeping high quality-assured screening of all
donated blood and blood components used for transfusion
will also help. Additionally, infection control precautions in
health care settings will significantly help prevent the trans-
mission of the infection. Similarly, safe injection practices
can protect against HBV transmission.
In conclusion, the present study further highlights the
effectiveness of vaccination in preventing HBV infection.
However, in addition to vaccination, strict preventive mea-
sures need to be encouraged in the study area.
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 The study was based entirely on the recall of the in-
terviewees, and thus, there is an inherent recall bias.
 No further investigations were performed regarding other
markers of HBV infection.Author’s contribution
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